Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis - Trial 2020-000875-20
Access comprehensive clinical trial information for 2020-000875-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pfizer Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Change from baseline in TSS in target lesions treated with crisaborole ointment or vehicle on Day 15 in each regimen (Regimen 1: QD, Regimen 2: BID) for each cohort
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2020-000875-20
Non-Device Trial